Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension

Pulmonary Circulation

Volumn 6, Issue 3, 2016, Pages 313-321

  Assad, Tufik R ^a   Brittain, Evan L ^a   Wells, Quinn S ^a   Farber Eger, Eric H ^b   Halliday, Stephen J ^a   Doss, Laura N ^a   Xu, Meng ^c   Wang, Li ^c   Harrell, Frank E ^c   Yu, Chang ^c   Robbins, Ivan M ^a   Newman, John H ^a   Hemnes, Anna R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Postcapillary; Precapillary; Pulmonary hypertension; Pulmonary vascular compliance; Pulmonary vascular resistance; Resistance compliance time

Indexed keywords

EID: 84987608244     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.1086/688516     Document Type: Article

References (49)

1. Robbins IM, Hemnes AR, Pugh ME, Brittain EL, Zhao DX, Piana RN, Fong PP, Newman JH. High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail 2014;7(1):116–122.
2. Fox BD, Shimony A, Langleben D, Hirsch A, Rudski L, Schlesinger R, Eisenberg MJ, et al. High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J 2013;42(4):1083–1091.
3. Fujimoto N, Borlaug BA, Lewis GD, Hastings JL, Shafer KM, Bhella PS, Carrick-Ranson G, Levine BD. Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation 2013;127 (1):55–62.
4. Andersen MJ, Olson TP, Melenovsky V, Kane GC, Borlaug BA. Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure. Circ Heart Fail 2015;8(1):41–48.
5. Naeije R, Vachiéry JL, Yerly P, Vanderpool R. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 2013;41(1):217–223.
6. Torres-Macho J, Delgado-Jiménez JF, Sanz-Salvo J, González-Mansilla A, Sánchez-Sánchez V, Gámez-Díez S, Escribano-Subías P, Sáenz de la Calzada C. Predictors of pulmonary hypertension in patients with end-stage heart failure. Congest Heart Fail 2012;18(4):212–216.
7. Ohara T, Ohte N, Little WC. Pulmonary hypertension in heart failure with preserved left ventricular ejection fraction: diagnosis and management. Curr Opin Cardiol 2012;27(3):281–287.
8. Delgado JF, Conde E, Sánchez V, López-Ríos F, Gómez-Sánchez MA, Escribano P, Sotelo T, Gómez de la Cámara A, Cortina J, Sáenz de la Calzada C. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail 2005;7(6):1011–1016.
9. Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol 2013;62(25 suppl):D100–D108.
10. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaïci A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173(9):1023–1030.
11. McGoon MD, Krichman A, Farber HW, Barst RJ, Raskob GE, Liou TG, Miller DP, Feldkircher K, Giles S. Design of the REVEAL registry for US patients with pulmonary arterial hypertension. Mayo Clin Proc 2008;83(8):923–931.
12. Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med 2012;186(8):790–796.
13. Reuben SR. Compliance of the human pulmonary arterial system in disease. Circ Res 1971;29(1):40–50.
14. Lankhaar JW, Westerhof N, Faes TJ, Marques KM, Marcus JT, Postmus PE, Vonk-Noordegraaf A. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 2006;291(4):H1731–H1737.
15. Saouti N, Westerhof N, Helderman F, Marcus JT, Stergiopulos N, Westerhof BE, Boonstra A, Postmus PE, Vonk-Noordegraaf A. RC time constant of single lung equals that of both lungs together: a study in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009;297(6):H2154–H2160.
16. Lankhaar JW, Westerhof N, Faes TJ, Gan CT, Marques KM, Boonstra A, van den Berg FG, Postmus PE, Vonk-Noordegraaf A. Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J 2008;29(13):1688–1695.
17. MacKenzie Ross RV, Toshner MR, Soon E, Naeije R, Pepke-Zaba J. Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol 2013; 305(2):H259–H264.
18. Hadinnapola C, Li Q, Su L, Pepke-Zaba J, Toshner M. The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease. Physiol Rep 2015;3(4):e12363. doi:10.14814 /phy2.12363.
19. Tedford RJ, Hassoun PM, Mathai SC, Girgis RE, Russell SD, Thiemann DR, Cingolani OH, et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 2012;125(2):289–297.
20. Dragu R, Rispler S, Habib M, Sholy H, Hammerman H, Galiè N, Aronson D. Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension. Eur J Heart Fail 2015;17(1):74–80.
21. Gerges M, Gerges C, Pistritto A-M, Lang MB, Trip P, Jakowitsch J, Binder T, Lang IM. Pulmonary hypertension in heart failure: epidemiology, right ventricular function, and survival. Am J Respir Crit Care Med 2015;192(10):1234–1246.
22. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gómez Sánchez MA, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62(25 suppl):D34–D41.
23. Roden DM, Pulley JM, Basford MA, Bernard GR, Clayton EW, Balser JR, Masys DR. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther 2008;84(3):362–369.
24. Pulley J, Clayton E, Bernard GR, Roden DM, Masys DR. Principles of human subjects protections applied in an opt-out, de-identified biobank. Clin Transl Sci 2010;3(1):42–48.
25. Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, Joynt KE, et al. Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program. Circulation 2016;133(13):1240–1248.
26. Brittain E, Chan S. Integration of complex data sources to provide biologic insight in pulmonary vascular disease (2015 Grover Conference Series). Pulm Circ 2016;6(3):251–260.
27. Kovacs G, Avian A, Pienn M, Naeije R, Olschewski H. Reading pulmonary vascular pressure tracings: how to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med 2014;190(3): 252–257.
28. LeVarge BL, Pomerantsev E, Channick RN. Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension. Eur Respir J 2014;44(2):425–434.
29. Boerrigter BG, Waxman AB, Westerhof N, Vonk-Noordegraaf A, Systrom DM. Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects. Eur Respir J 2014;43(5):1316–1325.
30. Ryan JJ, Rich JD, Thiruvoipati T, Swamy R, Kim GH, Rich S. Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J 2012;163(4):589–594.
31. Berger G, Hardak E, Obaid W, Shaham B, Carasso S, Kerner A, Yigla M, Azzam ZS. Characterization of pulmonary venous hypertension patients with reactive pulmonary hypertension as compared to proportional pulmonary hypertension. Respiration 2012;83(6):494–498.
32. Adir Y, Humbert M, Sitbon O, Wolf R, Lador F, Jaïs X, Simonneau G, Amir O. Out-of-proportion pulmonary hypertension and heart failure with preserved ejection fraction. Respiration 2013;85(6):471–477.
33. Miller WL, Grill DE, Borlaug BA. Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. JACC Heart Fail 2013;1(4):290–299.
34. Thenappan T, Shah SJ, Gomberg-Maitland M, Collander B, Vallakati A, Shroff P, Rich S. Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction. Circ Heart Fail 2011;4(3):257–265.
35. Gerges C, Gerges M, Lang MB, Zhang Y, Jakowitsch J, Probst P, Maurer G, Lang IM. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in “out-of-proportion” pulmonary hypertension. Chest 2013;143(3):758–766.
36. Harvey RM, Enson Y, Ferrer MI. A reconsideration of the origins of pulmonary hypertension. Chest 1971;59(1):82–94.
37. Naeije R. Measurement to predict survival: the case of diastolic pulmonary gradient. JACC Heart Fail 2015;3(5):425.
38. Galiè N, Humbert M, Vachiéry JL, Gibbs S, Lang I, Torbicki A, Simonneau G, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015;46(4):903–975.
39. Newman JH, Brittain EL, Robbins IM, Hemnes AR. Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension. Chest 2015;147(4):1080–1085.
40. Pellegrini P, Rossi A, Pasotti M, Raineri C, Cicoira M, Bonapace S, Dini FL, et al. Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. Chest 2014;145(5):1064–1070.
41. Mahapatra S, Nishimura RA, Sorajja P, Cha S, McGoon MD. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 2006;47(4):799–803.
42. Al-Naamani N, Preston IR, Paulus JK, Hill NS, Roberts KE. Pulmonary arterial capacitance is an important predictor of mortality in heart failure with a preserved ejection fraction. JACC Heart Fail 2015;3(6): 467–474.
43. Naeije R. Pulmonary vascular resistance. a meaningless variable? Intensive Care Med 2003;29(4):526–529.
44. Naeije R. Physiology of the pulmonary circulation and the right heart. Curr Hypertens Rep 2013;15(6):623–631.
45. Chemla D, Lau EM, Papelier Y, Attal P, Hervé P. Pulmonary vascular resistance and compliance relationship in pulmonary hypertension. Eur Respir J 2015;46(4):1178–1189.
46. Saouti N, Westerhof N, Postmus PE, Vonk-Noordegraaf A. The arterial load in pulmonary hypertension. Eur Respir Rev 2010;19(117):197–203.
47. Castelain V, Hervé P, Lecarpentier Y, Duroux P, Simonneau G, Chemla D. Pulmonary artery pulse pressure and wave reflection in chronic pulmonary thromboembolism and primary pulmonary hypertension. J Am Coll Cardiol 2001;37(4):1085–1092.
48. Tedford RJ. Determinants of right ventricular afterload (2013 Grover Conference series). Pulm Circ 2014;4(2):211–219.
49. Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest 2009;136(1):37–43.